A meta-analysis that evaluated the role of copeptin in prognostic prediction after ischemic stroke revealed that high levels of copeptin (tenfold increase) were associated with poor functional outcomes within 3 months or 1 year after stroke (Xu et al., 2017). Here, AVP is linked to Stroke.